Nallengare Pharmaceuticlas Pvt Ltd
About Nallengare Pharmaceuticlas Pvt Ltd
Data last updated:
Nallengare Pharmaceuticlas Pvt Ltd is a private limited company based in Thrissur, Kerala, India. It operates in the chemical products segment of the chemicals sector. It was incorporated on 21 July 1983 and has been in existence for over 43 years.
The company is registered with the Registrar of Companies (ROC), Ernakulam, under CIN U24231KL1983PTC003760.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Paul Varghese (Managing Director) and Milly Varghese.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at XI/336 Caico Road Ollur, Thrissur, Kerala, India – 680006.
As per the financials filed for FY 2025, the company reported a revenue of ₹5.66 Lakh, a growth of 8% compared to the previous year. For the same year it recorded a net profit of ₹13,515 (net margin 2.4%) and EBITDA of ₹18,352 (EBITDA margin 3.2%). Revenue has grown at a compounded annual rate (CAGR) of 10% over three years and 10% over five years.
As per MCA filings, the company has open charges of ₹8.7 Lakh on record.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Nallengare Pharmaceuticlas Pvt Ltd's registered office is in Thrissur, Kerala. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressXI/336 Caico Road Ollur, Thrissur, Kerala, India – 680006
- IndustryChemicals, Chemical Products, Medicinal Chemical & Botanical Products, Pharmaceuticals
To see the full contact details of Nallengare Pharmaceuticlas Pvt Ltd, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Nallengare Pharmaceuticlas Pvt Ltd
FY 2025 filings availableNallengare Pharmaceuticlas Pvt Ltd reported revenue of ₹5.66 Lakh (up 8% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 10% over five years, including 8% growth in the latest year. EBITDA rose 31% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹18,352 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹13,515 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 3.2% | ||||
| Net Profit Margin | 2.4% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Nallengare Pharmaceuticlas Pvt Ltd, buy the company report.
Board of directors of Nallengare Pharmaceuticlas Pvt Ltd
Nallengare Pharmaceuticlas has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Paul Varghese Also directs: Roterende Properties Private Limited | Managing Director | 28 Sep 2010 | 16 Years 1 Months | Current |
| Milly Varghese | Director | 21 Jul 1983 | 43 Years 3 Months | Current |
Auditor
Nallengare Pharmaceuticlas Pvt Ltd is audited by SURENDRANATH ELASSERY for the financial year 2017.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| SURENDRANATH ELASSERY | FY 2017 | 031156 |
Shareholding
The shareholding of Nallengare Pharmaceuticlas Pvt Ltd is on record for 3 financial years, the latest being FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 | FY 2016 | FY 2015 |
|---|---|---|---|
| Promoters | |||
| Domestic institutional investors (DII) | |||
| Foreign institutional investors (FII) | |||
| Public | |||
| Others |
To see the full shareholding pattern of Nallengare Pharmaceuticlas Pvt Ltd, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 01 Mar 2001 | 90018148 | Sampanna Kuries (P) Ltd | ₹4.55 Lakh | Open | |
| 12 Jul 1988 | 90015677 | Gampanra Furies (I) Ltd | ₹1.8 Lakh | Open | |
| 18 Dec 1986 | 90015589 | Federal Bank Ltd | ₹15,000 | Open | |
| 29 Apr 1986 | 90015554 | South Indian Bank Ltd | ₹1.2 Lakh | Open | |
| 26 Oct 1984 | 90015479 | The South Indian Bank Limited | ₹1 Lakh | Open |
Total charge records: 5 View all charges
Legal cases
No court or tribunal cases involving Nallengare Pharmaceuticlas Pvt Ltd are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Nallengare Pharmaceuticlas Pvt Ltd; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Nallengare Pharmaceuticlas Pvt Ltd; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Nallengare Pharmaceuticlas Pvt Ltd has 3 board changes on record since 1983: 2 appointments and 1 cessation. The latest: Nallengara Verghese Paul ceased to be Managing Director on 21 Nov 2010.
Frequently asked questions
Nallengare Pharmaceuticlas is an active private limited company based in Thrissur, Kerala, India. The company works in chemical products, within the chemicals industry. It was incorporated on 21 July 1983 (43+ years old) and is registered under CIN U24231KL1983PTC003760.
Nallengare Pharmaceuticlas has 2 current directors:
- Paul Varghese - Managing Director
- Milly Varghese - Director
The latest financial statements of Nallengare Pharmaceuticlas on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The CIN (Corporate Identification Number) of Nallengare Pharmaceuticlas is U24231KL1983PTC003760. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Nallengare Pharmaceuticlas was incorporated on 21 July 1983, making it 43+ years old. It is registered with the Registrar of Companies, Ernakulam.
Nallengara Verghese Paul ceased to be Managing Director on 21 Nov 2010. Paul Varghese was appointed as Managing Director on 28 Sep 2010. Milly Varghese was appointed as Director on 21 Jul 1983.
The registered office of Nallengare Pharmaceuticlas is at XI336 Caico Road Ollur, Thrissur, Kerala, India – 680006.
Nallengare Pharmaceuticlas operates in the chemicals industry, in the chemical products segment.
Nallengare Pharmaceuticlas has open charges of ₹8.7 Lakh and no satisfied charges on record as per latest MCA filings.
The compliance status of Nallengare Pharmaceuticlas is compliant as of 04 July 2026. The company is actively filing with the Registrar of Companies.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
